Filing Details
- Accession Number:
- 0001209191-18-047750
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-21 16:24:02
- Reporting Period:
- 2018-08-20
- Accepted Time:
- 2018-08-21 16:24:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1403708 | Evoke Pharma Inc | EVOK | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201886 | F Patrick Latterell | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No | |
1332654 | L.p. Iii Ventures Science Life Lvp | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No | |
1341508 | Lvp Iii Associates, L.p. | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No | |
1384618 | Lvp Iii Partners Lp | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No | |
1581469 | Lvp Gp Iii, Llc | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No | |
1581471 | Lvpmc, Llc | 2603 Camino Ramon Suite 200 San Ramon CA 94583-4289 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-20 | 465,116 | $2.35 | 1,937,983 | No | 4 | P | Indirect | Directly owned by LVP III |
Common Stock | Acquisiton | 2018-08-20 | 23,256 | $2.35 | 96,897 | No | 4 | P | Indirect | Directly owned by Associates |
Common Stock | Acquisiton | 2018-08-20 | 11,628 | $2.35 | 48,449 | No | 4 | P | Indirect | Directly owned by Partners |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Directly owned by LVP III |
No | 4 | P | Indirect | Directly owned by Associates |
No | 4 | P | Indirect | Directly owned by Partners |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,250 | Indirect | Directly owned by LVPMC |
Footnotes
- The reported securities are owned directly by each of LVPMC, LLC ("LVPMC"), LVP Life Science Ventures III, L.P. ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. GP III may be deemed to have sole voting power and dispositive power over the shares held by LVP III, Associates and Partners. Each of GP III and Patrick Latterell, the managing member of GP III and the manager of LVPMC, may be deemed to share voting and dispositive power over the reported securities and disclaim beneficial ownership of the reported securities held by LVPMC, LVP III, Associates and Partners except to the extent of any pecuniary interest therein.